Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Companion Diagnostics

Erick Lin's Biography



Erick Lin, Manager, Illumina Inc

Erick Lin, M.D., Ph.D. is currently the Manager of Medical Affairs at Illumina, Inc. and is a board-certified pathologist with subspecialty training in Molecular Genetic Pathology. Dr. Lin graduated from Northwestern University Feinberg of Medicine as a Medical Scientist Training Program fellow in 2009. He then served as a Resident Physician in the Department of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA. After his residency, he completed his subspecialty fellowship training in Molecular Genetic Pathology, under the mentorship of Dr. Wayne Grody, M.D., Ph.D., and was a member of the clinical team involved in setting up the Clinical Exome Sequencing service at UCLA.

Erick Lin Image

When Genomics Meets Human Health

Tuesday, 28 October 2014 at 11:30

Add to Calendar ▼2014-10-28 11:30:002014-10-28 12:30:00Europe/LondonWhen Genomics Meets Human HealthSELECTBIOenquiries@selectbiosciences.com

The development of next-generation sequencing (NGS) technologies has made sequencing not only rapid and cost-effective, but also highly accurate and reproducible. These advances have increased the utility of NGS in clinical settings, with applications ranging from the identification of rare diseases to the detection of chromosomal abnormalities in maternal-fetal medicine. Deep sequencing and circulating free tumor DNA in the oncology space is also trending toward clinical utility. Regulatory clearance of NGS-based platforms and approval of clinical assays utilizing NGS technologies are also central to the widescale implementation of NGS in personalized medicine.


Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonCompanion DiagnosticsSELECTBIOenquiries@selectbiosciences.com